Brief: EyeGate Pharma - Appointed Keith Maher As Class III Director To Fill Vacancy Created By Resignation Of Peter Greenleaf
10/01/2020 21:37
Jan 10 (Reuters) - EyeGate Pharmaceuticals Inc EYEG.O :
* EYEGATE PHARMACEUTICALS - APPOINTED KEITH MAHER, M.D. AS
CLASS
III DIRECTOR TO FILL VACANCY CREATED BY RESIGNATION OF PETER
GREENLEAF
Source: (https://bit.ly/2R9kzKU)
Further company coverage: EYEG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing